[1] He WQ, Li CX. Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends. Gynecol Oncol 2021;163(3):583 − 92. http://dx.doi.org/10.1016/j.ygyno.2021.10.075CrossRef
[2] Zhao FH, Qiao YL. Cervical cancer prevention in China: a key to cancer control. Lancet 2019;393(10175):969 − 70. http://dx.doi.org/10.1016/s0140-6736(18)32849-6CrossRef
[3] Li XT, Zheng RS, Li XM, Shan HB, Wu Q, Wang Y, et al. Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014. Chin J Cancer Res 2017;29(6):477 − 86. http://dx.doi.org/10.21147/j.issn.1000-9604.2017.06.02CrossRef
[4] Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Department of Public Health. 1960. https://discover.libraryhub.jisc.ac.uk/search?ti=Cancer%20Mortality%20for%20Selected%20Sites%20In%2024%20Countries&rn=3.https://discover.libraryhub.jisc.ac.uk/search?ti=Cancer%20Mortality%20for%20Selected%20Sites%20In%2024%20Countries&rn=3
[5] Yang Y, Schulhofer-Wohl S, Fu WJ, Land KC. The intrinsic estimator for age-period-cohort analysis: what it is and how to use it. Am J Sociol 2008;113(6):1697 − 736. http://dx.doi.org/10.1086/587154CrossRef
[6] Wang JY, Bai ZQ, Gao XD, Zhang NP, Wang ZK. The effects of age, period, and cohort on the mortality of cervical cancer in three high-income countries: Canada, Korea, and Italy. Biomed Res Int 2021;2021:8829122. http://dx.doi.org/10.1155/2021/8829122CrossRef
[7] Wei M, Zhou W, Bi YY, Wang H, Liu Y, Zhang ZJ. Rising mortality rate of cervical cancer in younger women in urban China. J Gen Intern Med 2019;34(2):281 − 4. http://dx.doi.org/10.1007/s11606-018-4732-zCrossRef
[8] Sathishkumar K, Vinodh N, Badwe RA, Deo SVS, Manoharan N, Malik R, et al. Trends in breast and cervical cancer in India under national cancer registry programme: an age-period-cohort analysis. Cancer Epidemiol 2021;74:101982. http://dx.doi.org/10.1016/j.canep.2021.101982CrossRef
[9] Barchuk A, Bespalov A, Huhtala H, Chimed T, Laricheva I, Belyaev A, et al. Breast and cervical cancer incidence and mortality trends in Russia 1980-2013. Cancer Epidemiol 2018;55:73 − 80. http://dx.doi.org/10.1016/j.canep.2018.05.008CrossRef
[10] Guo MH, Xu J, Du JY. Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis. BMC Public Health 2021;21(1):1329. http://dx.doi.org/10.1186/s12889-021-11401-8CrossRef
[11] Zheng RS, Zhang SW, Zeng HM, Wang SM, Sun KX, Chen R, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Center 2022;2(1):1 − 9. http://dx.doi.org/10.1016/j.jncc.2022.02.002CrossRef
[12] Xia CF, Hu SY, Xu XQ, Zhao XL, Qiao YL, Broutet N, et al. Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. Lancet Public Health 2019;4(9):e462 − 72. http://dx.doi.org/10.1016/s2468-2667(19)30162-8CrossRef
[13] Ku Y, Li PY, Luo GF, Liu D, Zou HC. Cancer attributable to human papillomavirus infection in China: burden and trends. Cancer 2020;126(16):3719 − 32. http://dx.doi.org/10.1002/cncr.32986CrossRef
[14] Moon EK, Oh CM, Won YJ, Lee JK, Jung KW, Cho H, et al. Trends and age-period-cohort effects on the incidence and mortality rate of cervical cancer in Korea. Cancer Res Treat 2017;49(2):526 − 33. http://dx.doi.org/10.4143/crt.2016.316CrossRef
[15] Utada M, Chernyavskiy P, Lee WJ, Franceschi S, Sauvaget C, de Gonzalez AB, et al. Increasing risk of uterine cervical cancer among young Japanese women: comparison of incidence trends in Japan, South Korea and Japanese-Americans between 1985 and 2012. Int J Cancer 2019;144(9):2144 − 52. http://dx.doi.org/10.1002/ijc.32014CrossRef